Metraipolis › archive › dc_8a152d475798
Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review — Europe PMC PMID:42465572
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42465572
- DOI
- 10.3389/fonc.2026.1830731
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T12:09:18.780Z
- SHA-256 of the archived text
3ef641f0fef79acd9b780230bb4e1bcb6fe9525015065ed926000ed5a7ce76bb- Stable URL of this page
https://metraipolis.com/documento/dc_8a152d475798
How to cite
Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review — Europe PMC PMID:42465572 — Europe PMC (en), https://europepmc.org/article/MED/42465572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a152d475798 (Metraipolis archive dc_8a152d475798, sha256 3ef641f0fef79acd9b780230bb4e1bcb6fe9525015065ed926000ed5a7ce76bb)
BibTeX
@misc{dc8a152d475798,
title = {Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review — Europe PMC PMID:42465572},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42465572},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a152d475798; sha256 3ef641f0fef79acd9b780230bb4e1bcb6fe9525015065ed926000ed5a7ce76bb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42465572. Agents can read the archived copy with the MCP tool read_document.